LSBCF (LakeShore Biopharma Co) Ending Cash Position: $0.00 Mil (As of Mar. 2025)


What is LakeShore Biopharma Co Ending Cash Position?

LakeShore Biopharma Co LSBCF Ending Cash Position is $0.00 Mil as of Mar. 2025.

LakeShore Biopharma Co's Ending Cash Position for the quarter that ended in Mar. 2025 was $0.00 Mil.

LakeShore Biopharma Co's quarterly Ending Cash Position increased from Mar. 2024 ($-1.85 Mil) to Sep. 2024 ($0.00 Mil) but then stayed the same from Sep. 2024 ($0.00 Mil) to Mar. 2025 ($0.00 Mil).

LakeShore Biopharma Co's annual Ending Cash Position declined from Mar. 2023 ($53.75 Mil) to Mar. 2024 ($34.24 Mil) and declined from Mar. 2024 ($34.24 Mil) to Mar. 2025 ($14.83 Mil).

LakeShore Biopharma Co Ending Cash Position Related Terms

LakeShore Biopharma Co Ending Cash Position Historical Data

* Premium members only.

The historical data trend for LakeShore Biopharma Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LakeShore Biopharma Co Ending Cash Position Chart

LakeShore Biopharma Co Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25
Ending Cash Position
59.97 42.72 53.75 34.24 14.83

LakeShore Biopharma Co Semi-Annual Data
Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25
Ending Cash Position Get a 7-Day Free Trial Premium Member Only 20.80 35.61 -1.85 0.00 0.00

LakeShore Biopharma Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

LakeShore Biopharma Co's Ending Cash Position for the fiscal year that ended in Mar. 2025 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=34.011+-19.184
=14.83

LakeShore Biopharma Co's Ending Cash Position for the quarter that ended in Mar. 2025 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=0+0
=0.00

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of $0.00 Mil mean?
LakeShore Biopharma Co (LSBCF) has a Ending Cash Position of $0.00 Mil as of Mar. 2025. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on LakeShore Biopharma Co and its competitors.
Is LakeShore Biopharma Co's Ending Cash Position too high?
LakeShore Biopharma Co's current Ending Cash Position is $0.00 Mil.
How does LakeShore Biopharma Co's Ending Cash Position compare to ACUT and PPCB?
LakeShore Biopharma Co's Ending Cash Position of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Biotechnology company?
A good Ending Cash Position depends on the Biotechnology industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on LakeShore Biopharma Co and its competitors. LakeShore Biopharma Co's current Ending Cash Position is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LakeShore Biopharma Co stock overvalued right now?
LakeShore Biopharma Co (LSBCF) has a current Ending Cash Position of $0.00 Mil. The current Ending Cash Position is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For LakeShore Biopharma Co (LSBCF), the current Ending Cash Position is $0.00 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

LakeShore Biopharma Co Business Description

Address 38 Yongda Road, Building No. 2, Daxing Biomedical Industry Park, Daxing District, Beijing, CHN, 102629
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.